The global defibrillator market size was valued at USD 15.18 billion in 2025 and is projected to grow from USD 16.21 billion in 2026 to USD 27.46 billion by 2034, registering a CAGR of 6.81% during the forecast period from 2026 to 2034. North America dominated the defibrillator market with a market share of 38.6% in 2025.
A defibrillator is a medical device that delivers a controlled electrical shock to the heart to help restore a normal heart rhythm during life-threatening cardiac conditions such as sudden cardiac arrest. Defibrillators are available in different types, including automated external defibrillators (AEDs), implantable cardioverter-defibrillators (ICDs), and manual devices. They are widely used in hospitals, emergency services, clinics, and public spaces to provide rapid cardiac intervention.
Download a Free Sample To learn more about this report,
Smart Wearable Defibrillators Add Mobile-Based Patient Monitoring
Defibrillator market analysis shows that the need for continuous protection outside clinical settings is shifting wearable defibrillators toward connected systems with mobile monitoring capabilities. In April 2025, the FDA approved the Jewel Patch Wearable Cardioverter Defibrillator for adults at risk of sudden cardiac arrest who are not candidates for or decline an implantable defibrillator, with an optional mobile application and cloud-based software included in the approved system. This transition connects defibrillation therapy with digital monitoring and supports more continuous management of patients outside hospitals.
Extravascular ICDs Reduce Dependence on Transvenous Leads
Clinical interest in reducing complications associated with conventional transvenous systems is shifting implantable defibrillators toward extravascular lead configurations. The FDA-approved Aurora EV-ICD System uses an extravascular lead positioned outside the heart and vasculature, and its regulatory record continued to receive device updates in 2026. This transition provides an alternative defibrillation architecture that avoids placing the lead inside the venous system while retaining continuous arrhythmia monitoring and therapy capabilities.
Cardiac Care Infrastructure and Power-Management Advances Drive Market
Expansion of hospital cardiac-care infrastructure creates a demand-side requirement for defibrillators across emergency departments, intensive-care units, and cardiac-care facilities. Greater availability of specialized cardiac services increases the need for rapid rhythm management and resuscitation equipment. Hospital emergency rooms and cardiac units use defibrillators for patients experiencing life-threatening arrhythmias and cardiac arrest. This broader clinical infrastructure supports procurement opportunities for defibrillator manufacturers.
Advances in battery and power-management technologies strengthen the supply-side capabilities of defibrillator manufacturers by supporting longer operating periods and more reliable portable devices. Improved energy management can reduce device downtime and support dependable operation during emergency procedures. Portable AEDs and transport defibrillators benefit from efficient battery systems in ambulances, emergency departments, and public-access locations. These technology improvements expand manufacturers’ ability to develop and supply more practical defibrillation equipment.
High Defibrillator Costs and Trained Operator Shortages Restrain Market Expansion
High device and maintenance costs can make defibrillator procurement difficult for hospitals, emergency services, and public-access programs with constrained budgets. Purchase, battery replacement, servicing, and periodic equipment upgrades add to the total cost of ownership. These financial requirements can delay new installations and restrict adoption in cost-sensitive healthcare settings.
Limited availability of trained operators can reduce the effective deployment of defibrillators, particularly in emergency and public-access settings. Proper device use requires basic recognition of cardiac arrest, safe operation, and timely response during resuscitation. Training requirements can restrict utilization and slow broader adoption where qualified personnel are not readily available.
Public-Access Defibrillation and Rental Models Offer Growth Opportunities
Community organizations, schools, workplaces, sports facilities, and AED providers can expand public-access defibrillation programs across locations where rapid emergency response is important. ZOLL supports PAD programs through AEDs, program-management software, maintenance, and training services, creating revenue avenues beyond device sales, contributing to defibrillator market growth.
Medical equipment providers and defibrillator manufacturers can offer rental, maintenance, compliance monitoring, and training packages for organizations that prefer service-based procurement. ZOLL’s Rescue Ready Services and PlusTrac platform demonstrate how maintenance, program management, and software can generate recurring revenue alongside AED deployment.
Product Recalls and Cybersecurity Requirements Hinder Growth
Product recalls and reliability concerns can disrupt manufacturers’ operations, increase corrective-action requirements, and weaken confidence among healthcare providers. The FDA recorded a 2025 Class II recall of ZOLL Powerheart G5 AEDs, illustrating how device issues can require market corrections and affect procurement decisions. Such events can slow replacement cycles and create reputational pressure for manufacturers.
Cybersecurity requirements create additional product-development and compliance challenges as defibrillation systems incorporate connectivity and software-based functions. FDA guidance issued in 2026 requires manufacturers of qualifying cyber devices to address cybersecurity in device design and premarket submissions. These requirements can lengthen development processes and increase the resources needed to commercialize connected defibrillation technologies.
The implantable cardioverter defibrillators (ICDs) segment accounted for a share of 61.7% in 2025, due to their established role in preventing sudden cardiac death, continuous monitoring of cardiac rhythms, and ability to deliver immediate therapy for life-threatening ventricular arrhythmias.
The external defibrillators (ED) segment is expected to grow at a CAGR of 7.58% during the forecast period 2026-2034, driven by their increasing use in hospitals, emergency care, ambulances, and public-access settings, along with their rapid deployment during cardiac emergencies and advances in automated and portable defibrillation technologies.
Request Customizationto receive a tailored report.
The hospital segment accounted for a share of 46.2% in 2025, owing to the availability of specialized cardiac care facilities, trained medical professionals, emergency response capabilities, and established use of defibrillators for managing life-threatening cardiac arrhythmias.
The home healthcare segment is expected to grow at a CAGR of 8.73% during the forecast period 2026-2034, fueled by the increasing need for accessible cardiac care, growing use of portable defibrillation devices, and greater emphasis on timely emergency response outside hospital settings. The pre-hospital, public access market, and alternate care market segments are also expected to support market growth through emergency medical services, community-based cardiac care, and decentralized healthcare settings.
Speak to an Analystto discuss market opportunities.
The North America defibrillator market accounted for the largest regional share of 38.6% in 2025. Well-established emergency-care networks, widespread hospital infrastructure, and continued deployment of advanced cardiac resuscitation technologies are reinforcing the region’s position in the defibrillator market.
The U.S. defibrillator market is influenced by the American Heart Association’s 2030 goal of increasing the proportion of public out-of-hospital cardiac arrest cases receiving an AED before EMS arrival to more than 20%, while the Canada defibrillator market is shaped by an estimated 60,000 out-of-hospital cardiac arrests annually, highlighting continued scope for wider access to early defibrillation.
Unlock Regional Insightsto access country-level data, & regional trends.
The Asia Pacific defibrillator market is expected to grow at a CAGR of 8.91% during the forecast period 2026-2034, showcasing the fastest-growing regional market. Rising healthcare accessibility, expanding hospital networks, and the integration of advanced cardiac-care technologies are broadening the use of defibrillators across both urban and emerging healthcare settings.
The Japan defibrillator market is influenced by projections of continued out-of-hospital cardiac-arrest burden through 2030, while the China defibrillator market, South Korea defibrillator market, and India defibrillator market are positioned within an Asia-Pacific region where cardiovascular-disease burden is forecast through 2050 and WHO targets a 33.3% reduction in premature cardiovascular-disease mortality by 2030 across Southeast Asia, reinforcing the need for accessible cardiac emergency technologies.
The Europe defibrillator market accounted for a market share of 27.4% in 2025 and is expected to grow at a CAGR of 6.58% during the forecast period 2026-2034. Strong public-access defibrillation programs, established emergency response networks, and regulatory efforts focused on improving cardiac arrest outcomes are reinforcing the region’s market development.
The U.K. defibrillator market is likely to see wider public-access deployment as more than 110,000 defibrillators are already registered and new CPR/AED training is being incorporated into driving theory tests from 2026; the Germany defibrillator market is set to benefit from a planned nationwide registry linking publicly accessible defibrillators with emergency dispatch centers, while the France defibrillator market continues to see emphasis on accessible AED coverage, with 40,000-50,000 sudden deaths reported annually and national requirements for AED installation in designated public establishments.
The defibrillator market is moderately fragmented, with medical device manufacturers, cardiovascular technology companies, emergency-care equipment providers, and specialized defibrillator developers competing across hospital, emergency medical services, public access, and wearable applications. Stryker Corporation, Medtronic plc, Abbott, Boston Scientific Corporation, and Koninklijke Philips N.V. are among the leading players in the defibrillator market, collectively accounting for an estimated 65-70% of the global defibrillator market share, based on their established presence across external and implantable defibrillation technologies.
Established players compete primarily on device reliability, clinical performance, safety, product portfolio breadth, regulatory compliance, monitoring capabilities, connectivity, and global distribution networks, while emerging players in the defibrillator market ecosystem compete through compact designs, wearable technologies, advanced software, remote monitoring, AI-enabled features, rapid deployment, and user-friendly interfaces. The presence of established manufacturers alongside specialized technology companies reflects competition across external, implantable, and wearable defibrillation solutions.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Europe Surgical Equipment Market Size, Top Share and Forecast to 2034
Biofeedback Instrument Market Size, Share, Growth, Analysis, 2034
Cardiac Assist Devices Market Size, Share, Growth, 2034
Radiosurgery Market Size, Share, Growth, Analysis, Report, 2034
Interventional Cardiology Devices Market Size, Share, Growth, 2034
Smart Inhalers Market Size, Share, Growth, Analysis, Report, 2034
We are featured on:
sales@straitsresearch.com